financetom
Business
financetom
/
Business
/
Cytokinetics Insider Sold Shares Worth $275,250, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cytokinetics Insider Sold Shares Worth $275,250, According to a Recent SEC Filing
Mar 10, 2026 8:30 PM

04:36 PM EDT, 10/01/2025 (MT Newswires) -- Robert I Blum, Director, President & CEO, on October 01, 2025, sold 5,000 shares in Cytokinetics ( CYTK ) for $275,250. Following the Form 4 filing with the SEC, Blum has control over a total of 372,274 common shares of the company, with 368,108 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000106198325000007/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved